Search research articles
Contact Us
Filters
Showing results (11-20 of 19) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 19 results.
APL Bioengineering
|
October 13, 2025
When <i>in vitro</i> is not enough: <i>In silico</i> strategies to investigate functional and dynamical properties of large-scale neuronal assemblies
Francesca Callegari, Rachele Fabbri, Valerio Barabino, et al.
Trials
|
July 10, 2025
Realizing the benefits of the estimand framework when reporting and communicating clinical trial results-some recommendations
Vivian Lanius, Barbara Glocker, Christian Lösch, et al.
Frontiers in Cellular Neuroscience
|
September 27, 2024
Investigating the interplay between segregation and integration in developing cortical assemblies
Valerio Barabino, Ilaria Donati Della Lunga, Francesca Callegari, et al.
Resuscitation Plus
|
February 6, 2026
Association between early arterial pH, base excess and lactate and 24-h mortality and neurological outcomes after cardiac arrest and cardiopulmonary resuscitation: a translational study
Francesca Callegari, Daria De Giorgio, Giulia Merigo, et al.
Biofabrication
|
January 22, 2026
Scaffold-free assembly of cortical-hippocampal circuit from modular neurospheroids: a high- throughput platform to investigate network development and dynamics
Ilaria Donati Della Lunga, Francesca Callegari, Fabio Poggio, et al.
Brain : a Journal of Neurology
|
June 10, 2026
Developmental circuit instability in amyotrophic lateral sclerosis: from hyperexcitability to network collapse
Ilaria Donati Della Lunga, Letizia Cerutti, Valerio Barabino, et al.
CNS Neuroscience & Therapeutics
|
March 26, 2016
Rivastigmine Patch in Chinese Patients with Probable Alzheimer's disease: A 24-week, Randomized, Double-Blind Parallel-Group Study Comparing Rivastigmine Patch (9.5 mg/24 h) with Capsule (6 mg Twice Daily)
Zhen-Xin Zhang, Zhen Hong, Yan-Ping Wang, et al.
Pain
|
March 6, 2021
Efficacy and safety of EMA401 in peripheral neuropathic pain: results of 2 randomised, double-blind, phase 2 studies in patients with postherpetic neuralgia and painful diabetic neuropathy
Andrew S C Rice, Robert H Dworkin, Nanna B Finnerup, et al.
Clinical Neuropharmacology
|
January 18, 2014
Long-term safety of rivastigmine in parkinson disease dementia: an open-label, randomized study
Murat Emre, Werner Poewe, Peter Paul De Deyn, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 19) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 19 results.
APL Bioengineering
|
October 13, 2025
When <i>in vitro</i> is not enough: <i>In silico</i> strategies to investigate functional and dynamical properties of large-scale neuronal assemblies
Francesca Callegari, Rachele Fabbri, Valerio Barabino, et al.
Trials
|
July 10, 2025
Realizing the benefits of the estimand framework when reporting and communicating clinical trial results-some recommendations
Vivian Lanius, Barbara Glocker, Christian Lösch, et al.
Frontiers in Cellular Neuroscience
|
September 27, 2024
Investigating the interplay between segregation and integration in developing cortical assemblies
Valerio Barabino, Ilaria Donati Della Lunga, Francesca Callegari, et al.
Resuscitation Plus
|
February 6, 2026
Association between early arterial pH, base excess and lactate and 24-h mortality and neurological outcomes after cardiac arrest and cardiopulmonary resuscitation: a translational study
Francesca Callegari, Daria De Giorgio, Giulia Merigo, et al.
Biofabrication
|
January 22, 2026
Scaffold-free assembly of cortical-hippocampal circuit from modular neurospheroids: a high- throughput platform to investigate network development and dynamics
Ilaria Donati Della Lunga, Francesca Callegari, Fabio Poggio, et al.
Brain : a Journal of Neurology
|
June 10, 2026
Developmental circuit instability in amyotrophic lateral sclerosis: from hyperexcitability to network collapse
Ilaria Donati Della Lunga, Letizia Cerutti, Valerio Barabino, et al.
CNS Neuroscience & Therapeutics
|
March 26, 2016
Rivastigmine Patch in Chinese Patients with Probable Alzheimer's disease: A 24-week, Randomized, Double-Blind Parallel-Group Study Comparing Rivastigmine Patch (9.5 mg/24 h) with Capsule (6 mg Twice Daily)
Zhen-Xin Zhang, Zhen Hong, Yan-Ping Wang, et al.
Pain
|
March 6, 2021
Efficacy and safety of EMA401 in peripheral neuropathic pain: results of 2 randomised, double-blind, phase 2 studies in patients with postherpetic neuralgia and painful diabetic neuropathy
Andrew S C Rice, Robert H Dworkin, Nanna B Finnerup, et al.
Clinical Neuropharmacology
|
January 18, 2014
Long-term safety of rivastigmine in parkinson disease dementia: an open-label, randomized study
Murat Emre, Werner Poewe, Peter Paul De Deyn, et al.
Page
of 2